New shop levitra australia online viagradirect.net with a lot of generic and brand drugs with mean price and fast delivery.

Microsoft word - discography.doc

Patient Education Handout
LUMBAR DISCOGRAPHY (Disc Stimulation)

The discs of the spine may develop tears in the outside lining that holds the spongy, shock
absorber part of the disc inside. The disc may then become painful causing pain due to nerves
that grow into the disc where there should be none. Movement then causes severe back pain due
to these new nerves being compressed. These tears in the disc (called annular tears) may be
present due to disc degeneration or trauma. Discography is a highly refined diagnostic test used
to determine if there is one or more than one disc producing pain. It is a test to help Dr. Lalani
choose options for further treatment.
¾ WHAT IS LUMBAR DISCOGRAPHY (Discogram)? Discography, also known as disc
stimulation, involves x-ray guided (fluoroscopic) placement of several needles into the discs of the spine. Depending on the clinical situation, the patient may receive mild intravenous sedation prior to needle placement, then after needle placement is complete, each disc is sequentially injected with iodine containing contrast under fluoroscope x-ray views. The contrast pattern is evaluated from the x-ray images, but more importantly, the patient is questioned about the location, severity, and character of pain produced during the injection compared to the normal every day pain experienced. Normal discs do not hurt significantly during the injection. Since not all annular tears seen on MRI cause pain, discography is the only way to determine pain producing discs. After the injection is complete, the needles are removed. In some cases a CT scan will be performed shortly after the discography if needed. ¾ DO THE INJECTIONS HURT? The point of the procedure is to reproduce the normal
daily pain. During the injection, a second type of pain (due to the needles themselves) is usually felt to the right or left of the spine depending on the location of the needles, but this type of pain is different than the usual pain. ¾ RISKS: bleeding, infection of the disc space, nerve injury, spinal cord injury, spinal
headache, abscess or blood clots, paralysis are all rare risks that you should discuss with Dr. Lalani prior to the procedure ¾ SPECIAL INSTRUCTIONS BEFORE THE PROCEDURE: If any sedatives are to be
administered, then you should not eat or drink after midnight on day of the procedure unless
otherwise instructed.
DO TAKE ALL OTHER USUAL MEDICATIONS WITH SMALL
AMOUNTS OF WATER ON THE DAY OF THE PROCEDURE EXCEPT THE
MEDICINES BELOW
THAT SHOULD BE STOPPED SEVERAL DAYS IN ADVANCE
OF THE PROCEDURE You will need a driver afterwards that can stay in our
lobby during the entire time you are in our facility.

¾ MEDIATIONS TO STOP BEFORE THE PROCEDURE: Stop Plavix 7 days before the
procedure. Stop Ticlid ( ticlopidine) 14 days before the procedure. Stop
coumadin/warfarin 5 days before the procedure.

¾ DISCHARGE INSTRUCTIONS:
• Activity:
Rest on the day of the procedure and if possible for several days afterwards.
• Diet:
Resume normal diet
• Medications: Resume normal medications unless otherwise instructed. If you are given a
new prescription for narcotic pain medications, take as directed and remember pain medications
may require 45 minutes to reach their peak effect. Pain medications may make you dizzy or
drowsy.
• Dressing: You may have a small bandaid or bandaids placed over the injection site. This can
be removed the next day
Discomfort at the Injection Site: Apply ice wrapped in a washcloth for short periods of time
(20 minutes per hour) during the first 24 hours, then apply low to medium heat
• IV Site: There may be soreness and bruising around the IV site, which will go away in a few
days. A warm moist cloth placed over the area for half-hour periods several times a day will
sometimes help. Increased tenderness or red streaking around the area of the IV site or
increasing swelling of the hand requires attention. Our clinic needs to be notified if this occurs
Side Effects: A flare-up of pain lasting up to a week or more, is more common than not, and
is to be expected. An antibiotic and iodine dye are injected and only very rarely result in
difficulty breathing, rash, or severe dizziness. There is a possibility of a spinal fluid leak with
spinal headache (severe pain on sitting or standing that is significantly less when lying down)
especially if the usual approach to the disc is impossible due to bone spurs in your spine. If there
is any new loss of bladder control or bowel control (excessive and uncontrollable amounts), new
numbness or weakness, or fever of more than 101 with severe worsening back pain, contact our
office immediately.
EMERGENCY CONTACT TELEPHONE NUMBER 281-265-0225
• Return to Normal Activities: You may experience some numbness in one leg temporarily
and if this happens, contact our office immediately. Discography is not a treatment to reduce
pain, but is a diagnostic tool to replicate the normal pain the patient has. Therefore discography
will not result in any decrease in pain. Try to rest as much as possible the first several days after
the procedure.
• Anesthetic Effects: If sedation is given, refrain from operating motor vehicles within the first
12 hours after the injection and do not plan to make any important decisions such as signing
legal or important papers within the first 24 hours after the injection. Do not consume alcohol
within 12 hours after the injection.

Source: http://www.sugarlandpain.com/binary/org/SJM_PSP_206/doc/Discography.pdf

Microsoft word - utilizzo logo coni.docx

nte Morale R.D. 8 settembre 1896 n. 2093 FEDERAZIONE SPORTIVA NAZIONALE RICONOSCIUTA DAL CONI  Protocollo elettronico Napoli, 19 marzo 2013 Ai Sigg. Presidenti delle Società affiliate di giurisdizione Loro indirizzi e-mail Oggetto:: Utilizzo del Logo CONI. Con riferimento a varie problematiche emerse in merito all'utilizzo del logo del CONI si ritiene

Company: cubist pharmaceuticals, inc

Company: Cubist Pharmaceuticals, Inc. (CBST) Publication Date: November 17, 2003 Author: Eric Sharps, Ph.D. I have evaluated Cubist Pharmaceuticals, Inc. ("Cubist" or the "Company") for its suitability as a long investment. This report highlights the merits and risks for Cubist's future. Conclusion: Cubist is a third-tier biotechnology company likely to reach second-tier status in

Copyright © 2010-2014 Pdf Physician Treatment